Produktname:7-tert-butyl-3-(2,5-difluorophenyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine

IUPAC Name:5-({[7-tert-butyl-3-(2,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]oxy}methyl)-1-methyl-1H-1,2,4-triazole

CAS:286456-42-6
Molekulare Formel:C19H19F2N7O
Reinheit:95%+
Katalognummer:CM338507
Molekulargewicht:399.41

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM338507-100mg 4-5 Weeks ŔșŔ
CM338507-250mg 5-6 Weeks źźňƄ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:286456-42-6
Molekulare Formel:C19H19F2N7O
Schmelzpunkt:-
SMILES-Code:CN1N=CN=C1COC2=NN3C(C=C2C(C)(C)C)=NN=C3C4=CC(F)=CC=C4F
Dichte:
Katalognummer:CM338507
Molekulargewicht:399.41
Siedepunkt:
Mdl-Nr.:MFCD08690609
Lagerung:2-8°C

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

Related Products